By Christine Davis
Researchers from Florida Atlantic University’s Schmidt College of Medicine received a five-year research project grant totaling $1,738,565 from the National Eye Institute of the National Institutes of Health for a project that uses a new tissue engineering approach.
This research could help in the development of new therapies to prevent and treat cataracts.
The project is focused on identifying the role of lack of oxygen to the cells and tissues in the body, and oxygen on the formation of the eye lens.
In September, Boca Raton resident David A. Goldman, M.D., of Goldman Eye, performed eye surgery using a new type of trifocal lens. It is a high-tech option for people with cataracts to gain clear vision at all distances — near, mid and far — thus reducing the need for glasses after surgery.
An intraocular lens is a tiny, artificial lens. It replaces the eye’s natural lens when it is removed during cataract surgery. There is also a version that corrects astigmatism. While trifocal lenses have been available for years in other countries, they were approved by the FDA in August.
Goldman is a former assistant professor of clinical ophthalmology at the Bascom Palmer Eye Institute in Palm Beach Gardens. His office is at 3502 Kyoto Gardens Drive, Suite B, Palm Beach Gardens.
Watershed Treatment Programs closed its facilities at 4905 Park Ridge Blvd., Boynton Beach, and 200 Congress Park Drive, Delray Beach, in September, laying off 231 workers. The reason, according to news reports: “Unfortunately, due to addiction care industry trends the Watershed has had to close our doors to new admissions.”
Send health news to Christine Davis at email@example.com.